Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial

被引:424
|
作者
Bouman, CSC
Oudemans-van Straaten, HM
Tijssen, JGP
Zandstra, DF
Kesecioglu, J
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Anesthesiol, Utrecht, Netherlands
[4] Univ Utrecht, Med Ctr, Cardiothorac & Neurosurg Intens Care Unit, Utrecht, Netherlands
[5] Onze Lieve Vrouw Hosp, Dept Intens Care, Amsterdam, Netherlands
关键词
hemofiltration; acute renal failure; survival; ultrafiltrate; mechanical ventilation; shock; oliguria;
D O I
10.1097/00003246-200210000-00005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. To study the effects of the initiation time of continuous venovenous hemofiltration and of the ultrafiltrate rate in patients with circulatory and respiratory insufficiency developing early oliguric acute renal failure. The primary end points were mortality at 28 days and recovery of renal function. Design: A randomized, controlled, two-center study. Setting: The closed-format multidisciplinary intensive care units of a university hospital (30 beds) and a teaching hospital (18 beds). Patients and Interventions. A total of 106 ventilated severely ill patients who were oliguric despite Passive fluid resuscitation, inotropic support, and high-dose intravenous diuretics were randomized into three groups. Thirty-five patients were treated with early high-volume hemofiltration (72-96 L per 24 hrs), 35 patients with early low-volume hemofiltration (24-36 L per 24 hrs), and 36 patients with late low-volume hemofiltration (24-36 L per 24 hrs). Results. Median ultrafiltrate rate was 48.2 (42.3-58.7) mL(.)kg(-1.)hr(-1) in early high-volume hemofiltration, 20.1 (17.5-22.0) mL.kg(-1.)hr(-1) in early low-volume hemofiltration, and 19.0 (16.6-21.1) mL(.)kg(-1.)hr(-1) in late low-volume hemofiltration. Survival at day 28 was 74.3% in early high-volume hemofiltration, 68.8% in early low-volume hemofiltration, and 75.0% in late low-volume hemofiltration (p = .80). On. average, hemofiltration started 7 hrs after inclusion in the early groups and 42 hrs after inclusion in the late group. All hospital survivors had recovery of renal function at hospital discharge, except for one patient in the early low-volume hemofiltration group. Median duration of renal failure in hospital survivors was 4.3 (1.4-7.8) days in early high-volume hemofiltration, 3.2 (2.4-5.4) days in early low-volume hemofiltration, and 5.6 (3.1-8.5) days in late low-volume hemofiltration (p = .25). Conclusions: In the present study of critically ill patients with oliguric acute renal failure, survival at 28 days and recovery of renal function were not improved using high ultrafiltrate volumes or early initiation of hemofiltration.
引用
收藏
页码:2205 / 2211
页数:7
相关论文
共 50 条
  • [1] High-volume continuous venovenous hemofiltration reduces mortality in critically ill patients with acute renal failure
    R Van Ketel
    I Meynaar
    L Dawson
    S Sleeswijk Visser
    M Van Spreuwel-Verheijen
    P Tangkau
    Critical Care, 12 (Suppl 2):
  • [2] Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units
    Brause, M
    Neumann, A
    Schumacher, T
    Grabensee, B
    Heering, P
    CRITICAL CARE MEDICINE, 2003, 31 (03) : 841 - 846
  • [3] IMPROVED SURVIVAL RATE IN PATIENTS WITH POSTOPERATIVE ACUTE-RENAL-FAILURE TREATED WITH HIGH-VOLUME HEMOFILTRATION
    INTHORN, D
    STORCK, M
    HARTL, WH
    ZIMMERER, E
    ZENTRALBLATT FUR CHIRURGIE, 1991, 116 (16): : 961 - 968
  • [4] CONTINUOUS ARTERIOVENOUS HEMODIALYSIS AND CONTINUOUS VENOVENOUS HEMOFILTRATION IN BURN PATIENTS WITH ACUTE RENAL FAILURE
    Sun, I-Feng
    Lee, Su-Shin
    Lin, Sin-Daw
    Lai, Chung-Sheng
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2007, 23 (07): : 344 - 351
  • [5] Hepatoactive substances eliminated by continuous venovenous hemofiltration in acute renal failure patients
    Riegel, W
    Habicht, A
    Ulrich, C
    Köhler, H
    KIDNEY INTERNATIONAL, 1999, 56 : S67 - S70
  • [6] CONTINUOUS HIGH-VOLUME VENOUS-VENOUS HEMOFILTRATION IN THE MANAGEMENT OF ACUTE-RENAL-FAILURE
    WENDON, J
    BIHARI, D
    TINKER, J
    CRITICAL CARE MEDICINE, 1986, 14 (04) : 343 - 343
  • [7] Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous Venovenous Hemofiltration
    Arzuaga, A
    Maynar, J
    Gascón, AR
    Isla, A
    Corral, E
    Fonseca, F
    Sánchez-Izquierdo, JA
    Rello, J
    Canut, A
    Pedraz, JL
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (02): : 168 - 176
  • [8] Continuous venovenous hemofiltration in patients with several acute renal failure after acute miocard infarct
    Griskevicius, A.
    Audzijoniene, J.
    BLOOD PURIFICATION, 2007, 25 (04) : 348 - 348
  • [9] Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit
    Chang, JW
    Yang, WS
    Seo, JW
    Lee, JS
    Lee, SK
    Park, SK
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2004, 38 (05): : 417 - 421
  • [10] Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration
    Tegeder, I
    Neumann, F
    Bremer, F
    Brune, K
    Lötsch, J
    Geisslinger, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 50 - 57